当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2014年
22期
108-109
,共2页
张兰%欧阳晓波%杨秀蓉%何继东
張蘭%歐暘曉波%楊秀蓉%何繼東
장란%구양효파%양수용%하계동
甲状腺功能亢进症%小剂量%他巴唑
甲狀腺功能亢進癥%小劑量%他巴唑
갑상선공능항진증%소제량%타파서
Hyperthyroidism%Low-dose%Methimazole
目的:探讨小剂量他巴唑治疗甲状腺功能亢进症的临床疗效。方法选取雅安市第二人民医院收治的46例甲状腺功能亢进症患者,随机均分为对照组(大剂量他巴唑治疗,初始剂量:10 mg/次,3次/d,后改为10 mg/次,1次/d)和观察组(小剂量他巴唑治疗,剂量:15 mg/次,1次/d)。比较2组治疗前后血清游离三碘甲腺原氨酸FT 3、血清游离甲状腺素FT 4、促甲状腺激素TSH水平的变化、治疗总有效率和不良反应发生率的差异。结果观察组患者治疗后血清FT 3、FT 4、TSH水平和治疗总有效率分别为(10.95±1.23)μmol/L、(21.33±3.28)μmol/L、(0.27±0.05)mU/L、91.3%,与对照组比较差异无统计学意义;观察组不良反应发生率为17.4%,显著低于对照组的47.8%(P<0.05)。结论小剂量他巴唑治疗甲亢疗效确切,和大剂量比较无明显差异,小剂量他巴唑不良反应少。
目的:探討小劑量他巴唑治療甲狀腺功能亢進癥的臨床療效。方法選取雅安市第二人民醫院收治的46例甲狀腺功能亢進癥患者,隨機均分為對照組(大劑量他巴唑治療,初始劑量:10 mg/次,3次/d,後改為10 mg/次,1次/d)和觀察組(小劑量他巴唑治療,劑量:15 mg/次,1次/d)。比較2組治療前後血清遊離三碘甲腺原氨痠FT 3、血清遊離甲狀腺素FT 4、促甲狀腺激素TSH水平的變化、治療總有效率和不良反應髮生率的差異。結果觀察組患者治療後血清FT 3、FT 4、TSH水平和治療總有效率分彆為(10.95±1.23)μmol/L、(21.33±3.28)μmol/L、(0.27±0.05)mU/L、91.3%,與對照組比較差異無統計學意義;觀察組不良反應髮生率為17.4%,顯著低于對照組的47.8%(P<0.05)。結論小劑量他巴唑治療甲亢療效確切,和大劑量比較無明顯差異,小劑量他巴唑不良反應少。
목적:탐토소제량타파서치료갑상선공능항진증적림상료효。방법선취아안시제이인민의원수치적46례갑상선공능항진증환자,수궤균분위대조조(대제량타파서치료,초시제량:10 mg/차,3차/d,후개위10 mg/차,1차/d)화관찰조(소제량타파서치료,제량:15 mg/차,1차/d)。비교2조치료전후혈청유리삼전갑선원안산FT 3、혈청유리갑상선소FT 4、촉갑상선격소TSH수평적변화、치료총유효솔화불량반응발생솔적차이。결과관찰조환자치료후혈청FT 3、FT 4、TSH수평화치료총유효솔분별위(10.95±1.23)μmol/L、(21.33±3.28)μmol/L、(0.27±0.05)mU/L、91.3%,여대조조비교차이무통계학의의;관찰조불량반응발생솔위17.4%,현저저우대조조적47.8%(P<0.05)。결론소제량타파서치료갑항료효학절,화대제량비교무명현차이,소제량타파서불량반응소。
Objective To investigate the clinical effect of low-dose methimazole for the treatment of hyperthyroidism. Methods 46 cases of hyperthyroidism patients in our hospital were randomly divided into control group (received large-does methimazole therapy) and observation group (received low-dose methimazole therapy). The serum free tri-iodothyronine (FT 3), free thyroxine (FT 4), thyroid srimulating hormone (TSH) and levels before and after treatment, total effective rate and adverse reactions rate of two groups were compared. Results The serum FT 3, FT 4,TSH levels after treatment and total effective rate of two groups had no significantly difference. The adverse reactions rate of observation group was 17.4%, which was significantly lower than 47.8%of control group (P<0.05). Conclusion Both low-dose and large-does methimazole are effective for hyperthyroidism. They have no significantly difference in clinical effect while low-dose methimazole has a lower adverse reactions rate.